Results 271 to 280 of about 242,514 (346)
Some of the next articles are maybe not open access.
Effect of whole blood on insulin adsorption onto intravenous infusion systems
American Journal of Health-System Pharmacy, 1980Insulin availability following the addition of whole blood to insulin infusions was evaluated. Solutions of 0.45% sodium chloride containing insulin (50) units/liter) and tracer amounts of 125I-labeled insulin were prepared and added to plastic or glass intravenous containers.
J, Kerchner, D M, Colaluca, R P, Juhl
openaire +3 more sources
Present and Future Expectations Regarding Insulin Infusion Systems
Diabetes Care, 1981E B, Marliss +3 more
openaire +3 more sources
Portable Insulin Infusion Systems in Juvenile-Onset Diabetes
Hospital Practice, 1980W. Tamborlane
openaire +3 more sources
Clinical significance of insulin adsorption by polyvinyl chloride infusion systems
American Journal of Health-System Pharmacy, 1977J I, Hirsch +3 more
openaire +3 more sources
Process-Aware Attacks on Medication Control of Type-I Diabetics Using Infusion Pumps
IEEE Systems Journal, 2023As medical infusion pumps are known to be vulnerable to cybersecurity threats, industrial reports, guidelines, and state-of-the art research have focused on securing such devices.
G. Stergiopoulos +3 more
semanticscholar +1 more source
Automatic Regulation of Basal Insulin Infusion in a Personalized Insulin Therapy System
Biomedical Engineering, 2021A method and a system for automatic regulation of the basal insulin administration rate for maintenance of glycemia in the target range are proposed. The method is based on proportional regulation of the infusion rate using feedback. It suspends the insulin delivery when the glucose level falls below a threshold value. According to the modeling results,
E. L. Litinskaia +2 more
openaire +1 more source
Diabetes Technology & Therapeutics, 2019
Background: Hybrid closed-loop (HCL) systems combine continuous glucose monitoring with continuous subcutaneous insulin infusion (CSII) to continuously self-adjust basal insulin delivery.
J. Jendle +4 more
semanticscholar +1 more source
Background: Hybrid closed-loop (HCL) systems combine continuous glucose monitoring with continuous subcutaneous insulin infusion (CSII) to continuously self-adjust basal insulin delivery.
J. Jendle +4 more
semanticscholar +1 more source
Newer Insulin Delivery Systems: Continuous Subcutaneous Insulin Infusion
1979The quest for new methods of administering insulin has been primarily stimulated by the practical difficulty of achieving long periods of strict blood glucose and major intermediary metabolites control with conventional insulin injection therapy.
J C, Pickup +3 more
openaire +2 more sources
Diabetes Research and Clinical Practice, 2022
AIMS To assess the efficacy and safety of ultra-rapid insulin analogues used with continuous subcutaneous insulin infusion systems (CSII) in adults with type 1 diabetes (T1DM).
Athina Stamati +3 more
semanticscholar +1 more source
AIMS To assess the efficacy and safety of ultra-rapid insulin analogues used with continuous subcutaneous insulin infusion systems (CSII) in adults with type 1 diabetes (T1DM).
Athina Stamati +3 more
semanticscholar +1 more source
Diabetes, 1976
This study was undertaken to determine the different consequences of portal and peripheral routes of insulin administration by the artificial endocrine pancreas. Intraportal glucose was infused (10 mg./min./kg. for 60 minutes) in anesthetized normal and pancreatectomized dogs while blood glucose concentrations were monitored continuously.
C K, Botz +4 more
openaire +2 more sources
This study was undertaken to determine the different consequences of portal and peripheral routes of insulin administration by the artificial endocrine pancreas. Intraportal glucose was infused (10 mg./min./kg. for 60 minutes) in anesthetized normal and pancreatectomized dogs while blood glucose concentrations were monitored continuously.
C K, Botz +4 more
openaire +2 more sources